cells that are CD38-Lin-45RA-90+ or (C) CD38-Lin-45RA-90-before (fresh) and after incubation with either STF or NOV+STF. Comparison of three separate UCB donations, p= NS (t-test). (D) Overlay histogram showing the extent of labelling of Jurkat cells after incubation with Alexa-488-labelled NOV protein, and blocking after pre-incubation with anti CD49f antibody for 2 hours. (E) Fold changes in absolute numbers of LTC-IC in STF and anti-CD49f+ STF treated 90+RA-cells. The number of LTC-IC in the unmanipulated cells inoculated into either culture is normalized to 1.0 (dashed line) and the mean foldchange + SEM in the absolute number of LTC-IC at the end of each culture calculated relative to this. n=5 UCB donations, mean + SEM, p (STF vs anti CD49f+STF) = 0.07. (A) CD34+ cells from 4UCB donations (CB1-CB4) were incubated in either STF or labelled NOV plus STF for 8 hours, and NOV-marked and STF treated 90+RA-were deposited as single cells onto LTC-IC stroma in 96 well format. The number of wells scoring as LTC-IC and the mean number of LTC-IC/100 cells are provided. A fifth UCB unit (CB5) was also studied, but the methylcellulose used in this experiment was from a different manufacturer. Nonetheless the trend of the results is the same. (B) CD34+ cells from 4 individual UCB donations (CB1-CB4) were incubated in either STF or STF plus labelled NOV for 8 hours and NOV-marked and STF treated 90+RA-were deposited as single cells into stem cell expansion medium supplemented with STF in 96 well format. After 14 days, the entire progeny of each cell was inoculated into LTC-IC. The number of wells scoring as LTC-IC and the mean number of LTC-IC/100 cells are provided. A fifth UCB donation (CB5) was also studied, but the methylcellulose used in this experiment was from a different manufacturer. Nonetheless the trend of the results is the same. Tables showing results of GSEA for transcripts associated with cellular quiescence (A) and glycolysis (B) between the RNASeq profiles of 90+RA-cells cultured in either STF or NOV+STF for 8 hours. There is no enrichment in the expression of markers of either cellular process. (ES enrichment score, NES normalized enrichment score, FDR false discovery rate, FWER family wise error rate Human engraftment in BM of 1˚NSG recipients of 10000 UCB CD34+ cells after 8 weeks. (A) Total human engraftment (Mean STF 31.9%, NOV+STF 33.4%p=NS) (B) Percentage of human cells that are CD34 + 38 lo 90 + (Mean STF 0.06%, NOV 0.33%, p=0.0002) (C) Percentage of human cells that are CD15 + (Mean STF 1.2%, NOV+STF 2.9%, p=0.0022). (D) Percentage of human cells that are CD19 + (Mean STF 87.4, NOV+STF 87.5%, % p=NS), CD33+ (Mean STF 3.9%, NOV+STF 5.1%,p=NS), CD13 + (Mean STF 4.3%, NOV+STF 3.7%, p=NS), CD14 + (Mean STF 3.6%, NOV+STF 3.7%, p=NS) and CD235 + (Mean STF 0.6% NOV+STF 0.8%, p=NS). (E) graph of LTC-IC frequencies in a single unit of mobilized peripheral blood CD34+ cells from a patient with a non-haematological disorder before (unmanipulated, red) and after incubation with NOV+STF (black). NOV+STF 1/336, unmanipulated 1/1134, p (NOV+STF v unmanipulated) = <0.01.
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